Market research
000078.SHE Shenzhen Neptunus Bioengineering Co., Ltd
SHE CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 4B
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.01
Community
Investor discussion
1 comment
Sign in to join the 000078.SHE discussion.
5 years, 5 months ago
Shenzhen Neptunus Bioengineering Co., Ltd is currently in a long term downtrend where the price is trading 9.6% below its 200 day moving average.
From a valuation standpoint, the stock is 97.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.2.
Shenzhen Neptunus Bioengineering Co., Ltd's total revenue rose by 10.4% to $11B since the same quarter in the previous year.
Its net income has dropped by 55.4% to $72M since the same quarter in the previous year.
Finally, its free cash flow fell by 6411.4% to $-616M since the same quarter in the previous year.
Based on the above factors, Shenzhen Neptunus Bioengineering Co., Ltd gets an overall score of 2/5.